LYKA LABS LTD. - 500259 - Prepayment Of Loan
We are pleased to inform you that the Company has pre-paid outstanding Term Loan -1 of Rs.64.70 Crores to International Asset Reconstruction Company Private Limited (IARC) on Saturday, 18th December, 2021. This is for your information. LYKA LABS LTD. - 500259 - Draft Letter of Offer
Arihant Capital Markets Ltd ("Managers to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Equity Shareholders of Lyka Labs Ltd ("Target Company"). Lyka Labs Ltd - 500259 - Updates on Open Offer
Arihant Capital Markets Ltd ("Managers to the Offer") has submitted to BSE a copy of Detailed Public Satement for the attention of the Equity Shareholders of Lyka Labs Ltd ("Target Company"). Lyka Labs Ltd - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mayank Jashwantlal Shah Lyka Labs Ltd - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prasham Shah Lyka Labs Ltd - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti Mayank Shah LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amee Parekh LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dalal & Broacha Stock Broking Pvt Ltd
Lyka Labs acquisition by Ipca Laboratories could open strong growth opportunities
Near-term growth potential seems to be moderate for Ipca Laboratories but the long-term growth levers are intact and the acquisition of Lyka Labs will likely open strong opportunities LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ipca Laboratories Ltd